Form 4/A for VCYT VERACYTE, INC.
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-03 · accession 0001384101-22-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2022-03-09 | 2022-03-04 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | S - Sale+OE | $25.12 | -23.0K | 67.3K | -25% | -$578.5K |
| DA | 2022-03-09 | 2022-03-04 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $5.98 | +4,407 | 84.4K | +6% | +$26.4K |
| DA | 2022-03-09 | 2022-03-03 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | A - Grant | $0.00 | +42.4K | 80.0K | +113% | $0 |
| DA | 2022-03-09 | 2022-03-04 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $0.00 | -4,407 | 0 | -100% | $0 |
| DA | 2022-03-09 | 2022-03-03 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | A - Grant | $0.00 | +77.3K | 77.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-04 | S | D | 5,844 | $25.70 | 61,461 | D | — | — | (F4) Represents weighted average sales price. Sale prices for the transactions range from $25.41 to $26.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
| 2 | Common | Common Stock | 2022-03-04 | S | D | 100 | $26.49 | 61,361 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-04 | M | A | 4,407 | $5.98 | 84,394 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-03 | A | A | 42,412 | $0.00 | 79,987 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-04 | S | D | 17,089 | $24.91 | 67,305 | D | — | — | (F3) Represents weighted average sales price. Sale prices for the transactions range from $24.40 to $25.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
| 6 | Derivative | Stock Option (right to buy) | 2022-03-04 | M | D | 4,407 | $0.00 | 0 | D | $5.98 · — to 2028-03-01 | 4,407 Common Stock | (F6) The option is fully vested. |
| 7 | Derivative | Stock Option (right to buy) | 2022-03-03 | A | A | 77,287 | $0.00 | 77,287 | D | $26.02 · — to 2032-03-03 | 77,287 Common Stock | (F5) The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. |